Clinical Trials Logo

Inappropriate ADH Syndrome clinical trials

View clinical trials related to Inappropriate ADH Syndrome.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04588207 Terminated - Hyponatremia Clinical Trials

Urea for Chronic Hyponatremia

Start date: December 28, 2021
Phase: Phase 2
Study type: Interventional

This study is examining how a dietary supplement called urea can be used to treat low blood sodium level. Low blood sodium level is a common problem and some studies show that many patients with low blood sodium level suffer from brain fog and/or loss of balance. Unfortunately, it is unknown at this point what the best treatment is for low blood sodium level. With this pilot research study, the investigators are hoping to learn more about whether urea is safe to take, whether patients can tolerate taking urea for several weeks, whether urea increases blood sodium level, and whether urea can help prevent the brain fog and/or loss of balance that some patients with low blood sodium level suffer from. The information obtained with this study is intended to be used to design a larger study in the future to get a definite answer whether urea is beneficial for patients with low blood sodium level.

NCT ID: NCT01227512 Terminated - Hyponatremia Clinical Trials

Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia

SALACIA
Start date: October 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if hospitalized patients with symptomatic hyponatremia treated with tolvaptan are in the hospital for less time than patients treated with fluid restriction. The study will also test if tolvaptan is better than fluid restriction in treating the symptoms of hyponatremia in hospitalized patients.

NCT ID: NCT00728091 Terminated - Hyponatremia Clinical Trials

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

AQUARIST1
Start date: July 2008
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to assess the efficacy of satavaptan versus placebo in patients with dilutional hyponatremia due to SIADH. Secondary objectives are to assess the safety of satavaptan, the maintenance of effect, and the clinical benefit in these patients.